Nebenwirkungen · Doptelet
Doptelet 20 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 12
HOS-140846 · Präparat HOS-098586
In the four pooled clinical trials in adult patients with chronic immune thrombocytopenia, thromboembolic events were observed in 7% (9/128) of patients. The only thromboembolic event which occurred in more than 1 individual patient was cerebrovascular accident, occurring in 1.6% (2/128). In paediatric patients with persistent or chronic immune thrombocytopenia, thromboembolic events occurred in 1.4% (1/73) of patients receiving avatrombopag.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-06-18T16:42:00Z · SHA-256 4aa299702805434ebd4ea8b3427376fdfed980657ef6db01eab3f2ed8a813c1d · Passage 7bd2b51694e10a3c871b02e423e2300fdee98e3a1aa8d898addb0a4686f33bba · Zeichen 8650–9096 im Abschnitt